Save the date! UPMC Viral Oncology Symposium
For more information contact: Dr. Shou-Jiang (SJ) Gao at: gaos8@upmc.eduGreg Benzy at benzyg@upmc.edu
For more information contact: Dr. Shou-Jiang (SJ) Gao at: gaos8@upmc.eduGreg Benzy at benzyg@upmc.edu
Read “Tackling cancer globally requires research commitments in LMICs”, the latest Worldview Editorial in Nature written by Dr. Satish Gopal, Director of the National Cancer Institute’s Center for Global Health. …
The Biden-Harris Administration, through NCI, is committing $5.4 million in the first year of these multi-year awards to support the inaugural cohort of 11 Cancer Moonshot Scholars. The inaugural cohort …
From Notice of Special Interest (NOSI): Pragmatic Trials in Low Resource Settings NOT-CA-23-078 NCI encourages applications for pragmatic clinical trials to generate evidence that directly informs decision-making among patients, providers, …
From RFA-CA-24-005 This Notice of Funding Opportunity (NOFO) supports the development of cancer-relevant technologies suitable for use in low- and middle-income countries (LMICs). Specifically, the NOFO solicits applications for projects …
NEW from the Frederick National Laboratory for Cancer Research, operated by Leidos Biomedical Research, Inc. for the National Cancer Institute. Recent research adds to growing evidence that a single dose …
National HIV Testing Day (NHTD) was first observed on June 27, 1995. This is a day to encourage people to get tested for HIV, know their status, and get linked …
Through this Notice of Special Interest (NOSI), NOT-CA-23-070 the National Cancer Institute (NCI) is a continuation of NOT-CA-20-022, “High” or “Medium” Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers, which expired …
BE HEARD! NIH is seeking public comment on updates to the NIH Grants Policy Statement (NIHGPS), Section 15.2, which outlines the requirements for consortium/subaward agreements on NIH-funded grants, including new …
Memo From the National Cancer Institute Registration is now open for the Summer 2023 Human Tumor Atlas Network (HTAN) hybrid meeting on June 12-13, 2023. HTAN—a Cancer Moonshot initiative—aims to produce …